Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the nurses' health study

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2525-2533

  Baik, Christina S ^a   Strauss, Gary M ^a   Speizer, Frank E ^b,c   Feskanich, Diane ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOLOGY; HORMONAL THERAPY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MORBIDITY; ONSET AGE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTIVE HISTORY; SMOKING; STRUCTURED QUESTIONNAIRE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; POSTMENOPAUSE; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 77958052700     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0450     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Can J Clin 2009;59:225-49.
2. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population study of 20,561 cases. Ann Oncol 2002;13:1087-93.
3. Patel JD. Lung cancer in women. J Clin Oncol 2005;23:3212-8.
4. Thun MJ, Lally CA, Glannery JT, Calle EE, Flanders WD, Heath CW. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-6.
5. Tam IYS, Chung LP, Suen WS, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 2006;12:1647-53.
6. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-46.
7. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
8. Shepherd FA, Pereira JR, Ciuleanu T, et al. Erlotinib in previously treated non-small cell lung cancer. N Engl J Med 2005;353:123-32.
9. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
10. Stabile LP, Gaither Davis AL, Gubish CT, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res 2002;62:2141-50.
11. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005;65:6450-8.
12. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005;65:1459-70. (Pubitemid 40270175)
13. Hammoud Z, Tan B, Badve S, Bigsby RM. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer 2008;15:475-83. (Pubitemid 351880836)
14. Rodriguez C, Spencer H, Deka A, et al. Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2008;17:655-60.
15. Ramnath N, Menezes RJ, Loewen G, et al. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 2007;73:305-10.
16. Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non-small-cell lung cancer in women. J Clin Oncol 2007;25:5785-92.
17. Chen KY, Hsiao CF, Chang GC, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer 2007;110:1768-75.
18. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004;10:113-23.
19. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007;120:2214-20.
20. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2006;73:331-5.
21. Blackman JA, Coogan PF, Rosenberg L, et al. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 2002;11:561-7.
22. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann H. Hormonal factors and risk of lung cancer among women? Int J Epidemiol 2003;32:263-71.
23. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005;117:662-6.
24. Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988;48:7279-84.
25. Taioli E, Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Nat Cancer Inst 1994;86:869-70.
26. Weiss JM, Lacey JV, Shu X, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008;168:1319-25.
27. Zatloukal P, Kubik A, Pauk N, Tomasek L, Petruzelka L. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer 2003;41:283-93.
28. Brenner AV, Wang Z, Kleinerman RA, et al. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol 2003;13:22-8.
29. Koushik A, Parent ME, Siemiatycki J. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer 2009;125:2428-33.
30. Feskanich D, Ziegler RG, Michaud DS. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000;92:1812-23.
31. Ries LAG, Eisner MP. Cancer of the Lung. In: Ries LAG, Young JL, Keel GE, et al, editors. SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. Bethesda: National Cancer Institute, SEER Program, NIH Pub. No 07-6215; 2007, p. 73-80.
32. Willett WC, Sampson LS, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1984;122:51-65.
33. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
34. Sondheimer SJ. Oral contraceptives: mechanism of action, dosing, safety and efficacy. Cutis 2008;81:S19-22.
35. Spivack SD, Hurteau GJ, Fasco MJ, Kaminsy LS. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res 2003;9:6002-11.
36. McDivitt AM, Greendale GA, Stanczyk FZ, Huang MH. Effects of alcohol and cigarette smoking on change in serum estrone levels in postmenopausal women randomly assigned to fixed doses of conjugated equine estrogens with or without a progestin. Menopause 2008;15:382-5.
37. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313:973-5.
38. Bjarnason NH, Wilkinson GR. Drug metabolism and variability. N Engl J Med 2005;353:955-6.
39. Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004;64:3119-25.
40. Han W, Pentecost BT, Bietropaolo RL, Fasco MJ, Spivack SD. Estrogen receptor a increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinogen 2005;44:202-11.
41. Chlebowski RT, Schwartz AG, Wakelee H, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51.
42. Slatore CG, Chien JW, Au DH, et al. Lung cancer and hormone replacement therapy: association in the Vitamins and Lifestyle Study. J Clin Oncol 2010;9:1540-6.